289 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Jakubowski
    Jakubowski
  4. Levine
    Levine
  5. Seo
    Seo
  6. Kernan
    Kernan
  7. Marks
    Marks
  8. Papadopoulos
    Papadopoulos
  9. Young
    Young
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (186)
  2. Center for Hematologic Malignancies (125)
  3. Hematologic Malignancies, Division of (125)
  4. GSK Faculty (74)
  5. Survivorship Research (59)
  6. Bone Marrow Transplant (57)
  7. Division of Subspecialty Medicine (45)
  8. Tow Center for Developmental Oncology (TCDO) (42)
  9. Solid Tumor Oncology Division (37)
  10. Adult Leukemia (35)
  1. "hematologic malignancy"
Formats
  1. Journal Article (234)
  2. Review (24)
  3. Research Letter (13)
  4. Editorial (6)
  5. Guidelines (4)
  6. Meeting Abstract (4)
  7. Book Section (2)
  8. Correspondence (2)
Groups
  1. Department of Medicine (186)
  2. Center for Hematologic Malignancies (125)
  3. Hematologic Malignancies, Division of (125)
  4. GSK Faculty (74)
  5. Survivorship Research (59)
  6. Bone Marrow Transplant (57)

More Groups

People
  1. Miguel-Angel Perales (25)
  2. Juliet Barker (18)
  3. Sergio Giralt (18)
  4. Ann Jakubowski (17)
  5. Ross Levine (12)
  6. Susan Seo (12)

More People

Years
  1. 2025 (13)
  2. 2024 (39)
  3. 2023 (22)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (15)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (21)
  2. Blood (14)
  3. Blood Advances (9)
  4. Bone Marrow Transplantation (9)
  5. Journal of Clinical Oncology (9)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. Nature Publishing Group (31)
  3. American Society of Hematology (23)
  4. Springer (16)
  5. Lippincott Williams & Wilkins (11)
  6. American Society of Clinical Oncology (10)

More Publishers

Results (289)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
    Journal Article

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M.; Wang, M.; Arnason, J.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Factors affecting diagnostic yield of lesional bone biopsy in hematologic malignancy patients
    Journal Article

    Cooke, T. M.; Maybody, M.; Aly, A. K.; Petre, E. N.; Santos, E.; Noy, A.; Chan, A. Y.; Lis, E.; Gangai, N.; Cornelis, F. H.; more...
    CardioVascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network
    Journal Article

    Booth, J. P.; Kennerly-Shah, J. M.; Kelley, L. R.; Capozzi, D.; Prescott, H. A.; Soefje, S. A.; Pace, M. B.; Barbour, S. Y.; Tizon, R. F.; DeVincenzo, S.; more...
    Journal of Oncology Pharmacy Practice (2023)

    Fulltext@MSK | Save
  • Bleeding in critically ill children with malignancy or hematopoietic cell transplant: A single-center prospective cohort study
    Journal Article

    Levasseur, J.; Fikse, L.; Mauguen, A.; Killinger, J. S.; Karam, O.; Nellis, M. E.
    Pediatric Critical Care Medicine (2023)

    Fulltext@MSK | Save
  • Patient blood management and its role in supporting blood supply
    Review

    Gammon, R. R.; Dubey, R.; Gupta, G. K.; Hinrichsen, C.; Jindal, A.; Lamba, D. S.; Mangwana, S.; Nair, A. R.; Nalezinski, S.; Bocquet, C.
    Journal of Blood Medicine (2023)

    Fulltext@MSK | Save
  • Advances in CAR T cell therapy for non-small cell lung cancer
    Review

    Ma, H. Y.; Das, J.; Prendergast, C.; De Jong, D.; Braumuller, B.; Paily, J.; Huang, S.; Liou, C.; Giarratana, A.; Hosseini, M.; more...
    Current Issues in Molecular Biology (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Epcoritamab + R2 regimen and responses in patients with high-risk follicular lymphoma, regardless of POD24 status
    Meeting Abstract

    Merryman, R. W.; Belada, D.; Sureda, A.; Leppä, S.; Vermaat, J. S. P.; Holte, H.; Hutchings, M.; Lugtenburg, P.; de Vos, S.; Abrisqueta, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Epcoritamab + R-CHOP in patients with previously untreated (1L) high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma: Updated EPCORE NHL-2 data
    Meeting Abstract

    Falchi, L.; Clausen, M. R.; Offner, F.; de Vos, S.; Brody, J.; Linton, K. M.; Snauwaert, S.; Cordoba, R.; Wu, J.; Bykhovski, I.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • The efficacy of tixagevimab–cilgavimab prophylaxis against Omicron BA.5 variants in patients with hematological malignancies: Insights from the Leukemia and Lymphoma Society Registry
    Research Letter

    Luttwak, E.; Noy, A.; Seshan, V.; Saltzman, L. A.; Greenberger, L. M.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save